rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
1997-12-9
|
pubmed:abstractText |
Baroreflex sensitivity is impaired in patients with systemic hypertension. The persistence of abnormal baroreflex sensitivity despite adequate blood pressure control may be one of the reasons why the effect of antihypertensive therapy on coronary artery disease mortality has been less than expected on the basis of the achieved blood pressure levels.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-9149
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1369-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9388120-Adult,
pubmed-meshheading:9388120-Antihypertensive Agents,
pubmed-meshheading:9388120-Baroreflex,
pubmed-meshheading:9388120-Case-Control Studies,
pubmed-meshheading:9388120-Female,
pubmed-meshheading:9388120-Heart Rate,
pubmed-meshheading:9388120-Humans,
pubmed-meshheading:9388120-Hypertension,
pubmed-meshheading:9388120-Male,
pubmed-meshheading:9388120-Middle Aged,
pubmed-meshheading:9388120-Reference Values
|
pubmed:year |
1997
|
pubmed:articleTitle |
Baroreflex sensitivity in drug-treated systemic hypertension.
|
pubmed:affiliation |
Department of Internal Medicine, and Biocenter Oulu, University of Oulu, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|